Copyright Reports & Markets. All rights reserved.

Global Melanocortin Receptor 4 Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Melanocortin Receptor 4

      • 1.1 Definition of Melanocortin Receptor 4
      • 1.2 Melanocortin Receptor 4 Segment by Type
        • 1.2.1 Global Melanocortin Receptor 4 Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Bremelanotide
        • 1.2.3 Corticotropin
        • 1.2.4 Cosyntropin
        • 1.2.5 Others
      • 1.3 Melanocortin Receptor 4 Segment by Applications
        • 1.3.1 Global Melanocortin Receptor 4 Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Metabolic Disorder
        • 1.3.3 Women's Health
        • 1.3.4 Genito Urinary System
        • 1.3.5 Infection Disease
        • 1.3.6 Others
      • 1.4 Global Melanocortin Receptor 4 Overall Market
        • 1.4.1 Global Melanocortin Receptor 4 Revenue (2014-2025)
        • 1.4.2 Global Melanocortin Receptor 4 Production (2014-2025)
        • 1.4.3 North America Melanocortin Receptor 4 Status and Prospect (2014-2025)
        • 1.4.4 Europe Melanocortin Receptor 4 Status and Prospect (2014-2025)
        • 1.4.5 China Melanocortin Receptor 4 Status and Prospect (2014-2025)
        • 1.4.6 Japan Melanocortin Receptor 4 Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Melanocortin Receptor 4 Status and Prospect (2014-2025)
        • 1.4.8 India Melanocortin Receptor 4 Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Melanocortin Receptor 4
      • 2.3 Manufacturing Process Analysis of Melanocortin Receptor 4
      • 2.4 Industry Chain Structure of Melanocortin Receptor 4

      3 Development and Manufacturing Plants Analysis of Melanocortin Receptor 4

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Melanocortin Receptor 4 Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Melanocortin Receptor 4
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Melanocortin Receptor 4 Production and Capacity Analysis
      • 4.2 Melanocortin Receptor 4 Revenue Analysis
      • 4.3 Melanocortin Receptor 4 Price Analysis
      • 4.4 Market Concentration Degree

      5 Melanocortin Receptor 4 Regional Market Analysis

      • 5.1 Melanocortin Receptor 4 Production by Regions
        • 5.1.1 Global Melanocortin Receptor 4 Production by Regions
        • 5.1.2 Global Melanocortin Receptor 4 Revenue by Regions
      • 5.2 Melanocortin Receptor 4 Consumption by Regions
      • 5.3 North America Melanocortin Receptor 4 Market Analysis
        • 5.3.1 North America Melanocortin Receptor 4 Production
        • 5.3.2 North America Melanocortin Receptor 4 Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Melanocortin Receptor 4 Import and Export
      • 5.4 Europe Melanocortin Receptor 4 Market Analysis
        • 5.4.1 Europe Melanocortin Receptor 4 Production
        • 5.4.2 Europe Melanocortin Receptor 4 Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Melanocortin Receptor 4 Import and Export
      • 5.5 China Melanocortin Receptor 4 Market Analysis
        • 5.5.1 China Melanocortin Receptor 4 Production
        • 5.5.2 China Melanocortin Receptor 4 Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Melanocortin Receptor 4 Import and Export
      • 5.6 Japan Melanocortin Receptor 4 Market Analysis
        • 5.6.1 Japan Melanocortin Receptor 4 Production
        • 5.6.2 Japan Melanocortin Receptor 4 Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Melanocortin Receptor 4 Import and Export
      • 5.7 Southeast Asia Melanocortin Receptor 4 Market Analysis
        • 5.7.1 Southeast Asia Melanocortin Receptor 4 Production
        • 5.7.2 Southeast Asia Melanocortin Receptor 4 Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Melanocortin Receptor 4 Import and Export
      • 5.8 India Melanocortin Receptor 4 Market Analysis
        • 5.8.1 India Melanocortin Receptor 4 Production
        • 5.8.2 India Melanocortin Receptor 4 Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Melanocortin Receptor 4 Import and Export

      6 Melanocortin Receptor 4 Segment Market Analysis (by Type)

      • 6.1 Global Melanocortin Receptor 4 Production by Type
      • 6.2 Global Melanocortin Receptor 4 Revenue by Type
      • 6.3 Melanocortin Receptor 4 Price by Type

      7 Melanocortin Receptor 4 Segment Market Analysis (by Application)

      • 7.1 Global Melanocortin Receptor 4 Consumption by Application
      • 7.2 Global Melanocortin Receptor 4 Consumption Market Share by Application (2014-2019)

      8 Melanocortin Receptor 4 Major Manufacturers Analysis

      • 8.1 AstraZeneca Plc
        • 8.1.1 AstraZeneca Plc Melanocortin Receptor 4 Production Sites and Area Served
        • 8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
        • 8.1.3 AstraZeneca Plc Melanocortin Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Mallinckrodt Plc
        • 8.2.1 Mallinckrodt Plc Melanocortin Receptor 4 Production Sites and Area Served
        • 8.2.2 Mallinckrodt Plc Product Introduction, Application and Specification
        • 8.2.3 Mallinckrodt Plc Melanocortin Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Obexia AG
        • 8.3.1 Obexia AG Melanocortin Receptor 4 Production Sites and Area Served
        • 8.3.2 Obexia AG Product Introduction, Application and Specification
        • 8.3.3 Obexia AG Melanocortin Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Palatin Technologies, Inc.
        • 8.4.1 Palatin Technologies, Inc. Melanocortin Receptor 4 Production Sites and Area Served
        • 8.4.2 Palatin Technologies, Inc. Product Introduction, Application and Specification
        • 8.4.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Pfizer Inc.
        • 8.5.1 Pfizer Inc. Melanocortin Receptor 4 Production Sites and Area Served
        • 8.5.2 Pfizer Inc. Product Introduction, Application and Specification
        • 8.5.3 Pfizer Inc. Melanocortin Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Retrophin Inc.
        • 8.6.1 Retrophin Inc. Melanocortin Receptor 4 Production Sites and Area Served
        • 8.6.2 Retrophin Inc. Product Introduction, Application and Specification
        • 8.6.3 Retrophin Inc. Melanocortin Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Rhythm Pharmaceuticals, Inc.
        • 8.7.1 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Production Sites and Area Served
        • 8.7.2 Rhythm Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.7.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served

      9 Development Trend of Analysis of Melanocortin Receptor 4 Market

      • 9.1 Global Melanocortin Receptor 4 Market Trend Analysis
        • 9.1.1 Global Melanocortin Receptor 4 Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Melanocortin Receptor 4 Regional Market Trend
        • 9.2.1 North America Melanocortin Receptor 4 Forecast 2019-2025
        • 9.2.2 Europe Melanocortin Receptor 4 Forecast 2019-2025
        • 9.2.3 China Melanocortin Receptor 4 Forecast 2019-2025
        • 9.2.4 Japan Melanocortin Receptor 4 Forecast 2019-2025
        • 9.2.5 Southeast Asia Melanocortin Receptor 4 Forecast 2019-2025
        • 9.2.6 India Melanocortin Receptor 4 Forecast 2019-2025
      • 9.3 Melanocortin Receptor 4 Market Trend (Product Type)
      • 9.4 Melanocortin Receptor 4 Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Melanocortin Receptor 4 Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Melanocortin Receptor 4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Melanocortin Receptor 4 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Melanocortin Receptor 4 market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Melanocortin Receptor 4 in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Melanocortin Receptor 4 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        AstraZeneca Plc
        Mallinckrodt Plc
        Obexia AG
        Palatin Technologies, Inc.
        Pfizer Inc.
        Retrophin Inc.
        Rhythm Pharmaceuticals, Inc.
        ...

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Bremelanotide
        Corticotropin
        Cosyntropin
        Others

        Segment by Application
        Metabolic Disorder
        Women's Health
        Genito Urinary System
        Infection Disease
        Others

        Buy now